Anti-Human CFD Recombinant Antibody
-
产品编号
YR1282
-
别名
科研级 Lampalizumab ( 兰帕利珠单抗 ), Anti-CFD Recombinant Antibody, Research Grade Lampalizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Lampalizumab ( 兰帕利珠单抗 ), Anti-CFD Recombinant Antibody, Research Grade Lampalizumab |
Catalog Number | YR1282 |
Molecular Name | Lampalizumab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | Fab-G1 Kappa |
Formulation | PBS, pH7.5 |
Background | Lampalizumab (INN) is an antigen-binding fragment of a humanized monoclonal antibody that binds to complement factor D, it was developed as a potential treatment of geographic atrophy (atrophy of the retinal cells, retinal pigment epithelium, and choriocapillaris) secondary to age-related macular degeneration. |
CAS Number | 1278466-20-8 |
Application | ELISA, IP, FCM, FuncS, Neut, IF, Stim |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | CFD[Homo sapiens] |